Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a direct-to-consumer telehealth platform for prescription and OTC health products, with its strongest political signal being a $90,000 lobbying spend in 2025 aligned with a Republican congresswoman who has made two purchases of the stock.
BusinessWhat HIMS does
Hims & Hers is a telehealth company that provides online access to healthcare professionals for prescription and over-the-counter treatments in areas like sexual health, dermatology, and mental wellness. Its business model is primarily direct-to-consumer via digital platforms, generating revenue from subscription services and one-time product sales. The company operates in the highly regulated healthcare sector.
Lifetime Government AwardsHIMS federal contracts
HIMS doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HIMS
Politicians Trading HIMSMembers of Congress with recent HIMS positions
Congressional TradesWho in Congress is trading HIMS
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting HIMSLive legislation impacting this stock
Political ProfileWhere HIMS sits in Washington
[object Object]
STRUCTURAL: Lobbying spend of $90,000 (`get_political_influence.lobbying.total_income`) is fully aligned with a member of the relevant Health, Employment, Labor, and Pensions subcommittee (`get_political_influence.lobbying_patterns[0].committees`). EVIDENTIARY: The same aligned politician, Rep. Lisa C. McClain, executed two separate purchases of HIMS stock in August 2025 (`Top congressional traders`). Net: Strong alignment between lobbying focus and a congresswoman's personal investment actions, against a backdrop of zero corporate insider buying (`get_corporate_insider_signal.total_buys: 0`).
Regulatory ExposureThreats & opportunities
Regulatory threats
-
High density of healthcare legislation affecting revenueU.S. Congress"`Recent bill_impacts` shows 8 recent bills with impact_ratios between 0.0045 and 0.0047, each with an estimated revenue impact over $15M."
Regulatory opportunities
-
Lobbying alignment with key health subcommittee memberHouse Committee on Education and the Workforce"`get_political_influence.lobbying_patterns[0].committees` shows Rep. Lisa C. McClain is a member of the Health, Employment, Labor, and Pensions (HELP) subcommittee (HSED02)."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for HIMS
Live signals + predictions for HIMS — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HIMS
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord